Skip to main content
SpringerLink
Log in

Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The purpose of this study was to evaluate a novel in situ micronization method avoiding any milling techniques to produce nano- or microsized drug particles by controlled crystallization to enhance the dissolution rate of poorly water-soluble drugs.

Methods. Ibuprofen, itraconazole, and ketoconazole microcrystals were prepared by the association of the previously molecularly dispersed drug using a rapid solvent change process. The drug was precipitated in the presence of stabilizing agents, such as hydrocolloids. The obtained dispersion was spray-dried. Particle size, morphology, dissolution rate, specific surface area, and wettability were analyzed. Physicochemical properties were characterized using differential scanning calorimetry and X-ray diffractometry.

Results. The obtained dispersions showed a homogeneous particle size distribution. Drugs are obtained in a mean particle size of approximately 2 μm and below. A high specific surface area was created and in situ stabilized. Different stabilizers showed differences in protecting the precipitated drug from crystal growth. The surface was hydrophilized because of the adsorbed stabilizer. Thus, a drug powder with markedly enhanced dissolution rate was obtained.

Conclusions. In situ micronization is a suitable method for the production of micro-sized drugs. This technique can be performed continuously or discontinuously and uses only common technical equipment. Compared to milled products drug properties are optimized as all particle surfaces are naturally grown, the particle size is more uniformly distributed and the powder is less cohesive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. R. Robinson. Recent advantages in formulation of poorly absorbed Drugs. In Current Status on Targeted Drug Delivery to the gastrointestinal tract, Capsugel Library, 1993 pp. 59-63.

  2. Y. Kawashima. Nanoparticulate systems for improved drug delivery. Adv. Drug Deliv. Rev. 47:1–2 (2001).

    Google Scholar 

  3. E. L. Parrott. Comminution. In J. Swarbrick, J. C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, Vol. 3., Marcel Decker Inc., New York, 1990 pp. 101–121.

    Google Scholar 

  4. L. Mackin, R. Zanon, J. M. Park, K. Foster, H. Opalenik, and M. Demonte. Quantification of low levels (< 10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry. Int. J. Pharm. 231:227–236 (2002).

    Google Scholar 

  5. M. D. Ticehurst, P. A. Basford, C. I. Dallman, T. M. Lukas, P. V. Marshall, G. Nichols, and D. Smith. Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide. Int. J. Pharm. 193:247–259 (2000).

    Google Scholar 

  6. L. Mackin, S. Sartnurak, I. Thomas, and S. Moore. The impact of low levels of amorphous material (< 5%) on the blending characteristics of a direct compression formulation. Int. J. Pharm. 231:213–226 (2002).

    Google Scholar 

  7. J. C. Feeley, P. York, B. S. Sumby, and H. Dicks. Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation. Int. J. Pharm. 172:89–96 (1998).

    Google Scholar 

  8. G. H. Ward and R. K. Schultz. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm. Res. 12:773–779 (1995).

    Google Scholar 

  9. R. J. Roberts, R. C. Rowe, and P. York. The relationship between indentation hardness of organic solids and their molecular structure. J. Mater. Sci. 29:2289–2296 (1994).

    Google Scholar 

  10. C. Jacobs, O. Kayser, and R. H. Müller. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int. J. Pharm. 196:161–164 (2000).

    Google Scholar 

  11. R. H. Müller, C. Jacobs, and O. Kayser. Nanosuspensions as Particulate Drug Formulations in Therapy. Rationale for Development and what We Can Expect for the Future. Adv. Drug Deliv. Rev. 47:2–19 (2001).

    Google Scholar 

  12. R. H. Müller, H. L. Böhm, and M. J. Grau. Nanosuspensionen-Formulierungen für schwerlösliche Arzneistoffe mit geringer Bioverfügbarkeit; 1. Herstellung und Eigenschaften. Pharm. Ind. 61:74–78 (1999).

    Google Scholar 

  13. E. Shalaev, M. Shalaeva, and G. Zografi. The effect of disorder on the chemical reactivity of an organic solid, tetraglycine methyl ester: change of the reaction mechanism. J. Pharm. Sci. 91:584–593 (2002).

    Google Scholar 

  14. J.-O. Waltersson and P. Lundgren. The effect of mechanical comminution on drug stability. Acta Pharm. Suec. 22:291–300 (1985).

    Google Scholar 

  15. V. Joshi, S. Dwivedi, and G. H. Ward. Increase in the specific surface area of budesonide during storage postmicronization. Pharm. Res. 19:7–12 (2002).

    Google Scholar 

  16. R. H. Müller, K. Peters, R. Becker, and B. Kruss. Nanosuspensions for the i.v. administration of poorly soluble drugs-stability during sterilization and long-term storage. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 22:574–575 (1996).

    Google Scholar 

  17. P. Ga?mann, M. List, A. Schweitzer, and H. Sucker. Hydrosols-Alternatives for the parenteral application of poorly watersoluble drugs. Eur. J. Pharm. Biopharm. 40:64–72 (1994).

    Google Scholar 

  18. D. Horn. Preparation and characterisation of microdisperse bioavailable carotenoid hydrosols. Angew. Makrom. Chem. 166:139–153 (1989).

    Google Scholar 

  19. H. Auweter, H. Bohn, H. Haberkorn, D. Horn, E. Luddecke, and V. Rauschenberger. Production of carotenoid preparations in the form of coldwater-dispersible powders, and the use of the novel carotenoid preparations, US patent no. 5,968,251, October 19, 1999.

  20. H. Steckel, J. Thies, and B. W. Müller. Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide. Int. J. Pharm. 152:99–110 (1997).

    Google Scholar 

  21. J. Kerc, S. Srcic, Z. Knez, and P. Sencar-Bozic. Micronization of drugs using supercritical carbon dioxide. Int. J. Pharm. 182:33–39 (1999).

    Google Scholar 

  22. N. Rasenack, and B. W. Müller. Verfahren zur Herstellung und Anwendung von Mikro-und Nanoteilchen durch aufbauende Mikronisation, German Patent Application No. 102 14 031.6 (2002).

  23. B. L. Pedersen, A. Müllertz, H. Brondsted, and H. G. Kristensen. A comparison of the solubility of danazol in human and simulated gastrointestinal fluids. Pharm. Res. 17:891–894 (2000).

    Google Scholar 

  24. V. P. Shah, J. J. Konecny, R. L. Everett, B. McCullough, A. C. Noorizadeh, and J. P. Skelly. In vitro dissolution profile of waterinsoluble drug dosage forms in the presence of surfactants. Pharm. Res. 6:612–618 (1989).

    Google Scholar 

  25. H. Schott. Colloidal Dispersions Gennaro A.R., Chase G.D., Gibson, M.R., Granberg, C.B., Harvey, S.C., King, R.E., Martin, A.N., Medwick, T., Swinyard, E.A., and Zink, G.L. (eds.). In: Remington's Pharmaceutical Sciences; The Philadelphia College of Pharmacy and Science, 1985, pp. 286–289 Philadelphia, Pennsylvania.

    Google Scholar 

  26. S. A. Chang and D. G. Gray. The surface tension of aqueous hydroxypropyl cellulose solutions. J. Colloid. Interface Sci. 67: 255–265 (1978).

    Google Scholar 

  27. R. Daniels and A. Barta. Pharmacopoeial cellulose ethers as oil-in-water emulsifiers. I. Interfacial Properties. Eur. J. Pharm. Biopharm. 40:128–133 (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics and Biopharmaceutics, Christian Albrecht University Kiel, Gutenbergstr. 76, 24118, Kiel, Germany

    Norbert Rasenack & Bernd W. Müller

Authors
  1. Norbert Rasenack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernd W. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernd W. Müller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rasenack, N., Müller, B.W. Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs. Pharm Res 19, 1894–1900 (2002). https://doi.org/10.1023/A:1021410028371

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021410028371

Search

Navigation